# FDA recall D-523-2015

> **Attix Pharmaceuticals** · Class II · drug recall initiated 2014-11-14.

## Product

Aprepitant active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

## Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

## Distribution

Nationwide to compounding pharmacies and research organizations.

## Key facts

- **Recall number:** D-523-2015
- **Recalling firm:** Attix Pharmaceuticals
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-11-14
- **Report date:** 2015-04-29
- **Termination date:** 2015-10-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Toronto, Canada

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-523-2015

## Citation

> AI Analytics. FDA recall D-523-2015. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-523-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*